Funding Rounds
Universal Diagnostics

Universal Diagnostics Series B (2023, $93M)

Universal Diagnostics

Colorectal cancer test platform.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $93.03M

Investors